Business Context and Reporting Period
This Form 8-K, filed on December 15, 2005, by PerkinElmer, Inc. (now REVVITY, INC.), provides Regulation FD disclosure regarding the company's Fluid Sciences business. In September 2005, the company approved a plan to sell this business unit. Consequently, the results of operations for Fluid Sciences have been segregated from continuing operations and reported as discontinued operations in GAAP filings. The filing includes reconciliations to non-GAAP Pro Forma Income Statements that present consolidated operations including Fluid Sciences as continuing operations for the nine months ended October 2, 2005, and the comparable period in 2004.
Key Financial Metrics
The filing provides detailed quarterly and year-to-date (YTD) financial data for the nine months ended October 2, 2005, compared to the same period in 2004. All figures are in thousands, except per share data.
| Metric | Q3 2005 YTD (GAAP) | Q3 2005 YTD (Pro Forma) | Q3 2004 YTD (GAAP) | Q3 2004 YTD (Pro Forma) |
|---|---|---|---|---|
| Total Sales | $1,092,270 | $1,261,606 | $1,028,396 | $1,207,035 |
| Operating Income (Continuing) | $90,239 | $113,493 | $85,063 | $114,915 |
| Net Income | $80,559 | $80,559 | $58,120 | $58,120 |
| Diluted EPS (Net Income) | $0.62 | $0.62 | $0.45 | $0.45 |
| Fluid Sciences Sales (YTD) | $169,336 | - | $178,639 | - |
The filing does not provide specific data on cash flow, debt levels, or liquidity ratios.
Material Changes Versus Prior Period
- Revenue Growth: Pro Forma total sales for the nine months ended October 2, 2005, increased to $1,261,606 from $1,207,035 in the prior year period, representing a 4.5% increase.
- Operating Income: Pro Forma operating income from continuing operations decreased slightly to $113,493 from $114,915 in the prior year period.
- Net Income: GAAP Net Income increased significantly to $80,559 from $58,120 in the prior year period. This increase is largely driven by a tax benefit of $3,151 in 2005 compared to a tax provision of $13,844 in 2004, and income from discontinued operations.
- Restructuring Costs: The company incurred $14,245 in restructuring and asset impairment charges in the 2005 period, which were not present in the comparable 2004 period.
- Discontinued Operations: Fluid Sciences contributed $169,336 in sales and $23,254 in operating income for the 2005 YTD period before being classified as discontinued.
Guidance, Outlook, and Management Commentary
Management states that the presentation of Pro Forma information including Fluid Sciences provides useful context for investors to understand core operating results and future prospects, consistent with how management measures performance. The filing does not contain specific forward-looking guidance, risk factors, or contingencies beyond the disclosure of the planned sale of the Fluid Sciences business.
Investor Verification Checklist
- Verify the final terms and closing date of the Fluid Sciences business sale.
- Confirm the impact of the $14.2 million restructuring charge on future cash flows.
- Review the tax benefit of $3.1 million in the 2005 period to understand its sustainability.
- Assess the performance of continuing operations excluding the one-time restructuring costs.
- Monitor the transition of Fluid Sciences results from continuing to discontinued operations in subsequent filings.